Peripheral Artery Disease

Peripheral artery disease (PAD) involves atherosclerosis mainly in the extremities, especially in the legs and feet that lead to ischemia. Untreated, PAD can progress to critical limb ischemia (CLI), also called chronic limb-threatening ischemia (CLTI), which will lead to foot or leg amputation. The mortality rate for these CLI amputees is 70% within three years. There is currently an epidemic of PAD and CLI in the U.S. The majority of patients are defined by health disparities concentrated in the Black, Latino, Native American populations in both rural and low-income urban areas. A large number of PAD patients have other comorbities, with diabetes being one a primary issue.

Drug-coated balloons make little impact on PAD outcomes
Researchers tracked data from more than 3,000 patients, calling for more clinical trials of antiproliferative agents other than paclitaxel.
Abbott’s dissolving stent picks up a key approval
It's another big victory for Abbott's bioresorbable stent for BTK PAD.
New liquid embolic agent for hypervascular tumors gains FDA’s premarket approval
Instylla's Embrace Hydrogel Embolic System minimizes bleeding risks during the embolization of hypervascular tumors in the peripheral arteries.
Medtronic expands peripheral portfolio with new distribution deal
The company has finalized an exclusive distribution deal with Future Medical Design to sell its stainless steel peripheral guidewires in the United States.
New guidelines help interventional cardiologists manage chronic venous disease
"These recommendations will help ensure that patient care remains both consistent and personalized," SCAI President Srihari S. Naidu, MD, explained.

Bypass surgery the best way to limit amputations, death among CLTI patients

Researchers examined data from more than 1,800 CLTI patients, comparing bypass surgery with minimally invasive treatment options such as angioplasty and stenting.

Late-breaking study examines IVL’s safety and effectiveness among real-life PAD patients

The new study, based on data from nearly 1,400 PAD patients who were treated with Shockwave Medical's IVL technology, was presented at VIVA22 in Las Vegas.

Peripheral artery disease patients benefit if they push through discomfort when walking

Researchers said they were surprised to learn that "no pain, no gain" was so accurate for this patient population.

Intravascular lithotripsy (IVL) Shockwave Medical PCI PAD CAD Disrupt PAD Disrupt CAD SCAI 2022

Intravascular lithotripsy tied to superior long-term PAD, PCI outcomes at SCAI 2022

Two separate sessions presented at SCAI 2022 focused on long-term outcomes associated with Shockwave Medical's IVL technology.

PAD specialists announce new FDA clearance for image-guided atherectomy system

The solution is now cleared as a treatment option for in-stent restenosis in the lower extremity arteries.

New survey examines the biggest issues impacting care for CAD, PAD patients

Physicians, industry leaders—and, yes, patients themselves—provided an updated look at the state of vascular care in 2021.

Hispanic PAD patients often face longer hospitalizations, higher costs

Hispanic adults with peripheral artery disease tend to seek care through the emergency department—and they are paying the price.

‘Saving lives and saving limbs’: New study of real-world CMS patients highlights the benefits of IVUS

The Smith Center for Outcomes Research in Cardiology examined real-world data from more than 700,000 CMS patients. The group's findings were presented during TCT 2021.

Peripheral Artery Disease

Drug-coated balloons make little impact on PAD outcomes

Abbott’s dissolving stent picks up a key approval

New liquid embolic agent for hypervascular tumors gains FDA’s premarket approval

Medtronic expands peripheral portfolio with new distribution deal

New guidelines help interventional cardiologists manage chronic venous disease